DY3002 is a novel Selective and Potent EGFR Inhibitor, Overcoming T790M-Mediated Resistance in Non-Small Cell Lung Cancer. References: Li Y, Song Z, Jin Y, Tang Z, Kang J, Ma X. Novel Selective and Potent EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer. Molecules. 2016 Nov 2;21(11). pii: E1462. PubMed PMID: 27827863.

纯度：≥98%

CAS：2020015-37-4